Ridgefield, CT, United States of America

Tatiana Shelekhin

This inventor holds 24 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 7 EPO patents, primarily in Ubiquitin Biology. Top assignees: Forma Therapeutics, Inc., Novo Nordisk Healthcare Ag, Valo Health, Inc.. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tatiana Shelekhin. Retrieved from https://idiyas.com/inventor/tatiana-shelekhin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 6)

% Patents Active = 79.2

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 7 (Patent Applications = 12)

Average Co-Inventor Count = 9.4

ph-index = 5

Forward Citations = 134(Granted Patents)

Location History:

Ridgefield, CT (US) (2003 - 2024)
Watertown, MA (US) (2024)

Company Filing History:

6 out of 125

Forma Therapeutics, Inc.

patents

5 out of 89

Novo Nordisk Healthcare Ag

Cara Therapeutics, Inc.

patents

5. 2 out of 71

Bayer Pharmaceuticals Corporation

patents

6. 2 out of 15

Valo Early Discovery, Inc.

Bayer Intellectual Property Gmbh

patents

Years Active: 2003-2026

Loading Chart...

Areas of Expertise:

Ubiquitin-Specific Protease Inhibitors

Pyruvate Kinase Activators

Cancer Treatment

Sickle Cell Disease

Carboxamides

Pyrrolopyrroles

Thienopyridines

Imidazoheterocycles

Beta-3 Adrenoreceptor Agonists

Obesity Treatment

Hyperproliferative Diseases

Cannabinoid Receptor Agonists

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760027 - Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators (2026-10-13),

2. 12252490 - Inhibiting deubiquitinase USP25 and USP28 (2025-03-18),

3. 12162888 - Carboxamides as ubiquitin-specific protease inhibitors (2024-12-10),

4. 12122778 - Activating pyruvate kinase R (2024-10-22),

5. 12071440 - Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators (2024-08-27),

6. 12053458 - Treating sickle cell disease with a pyruvate kinase R activating compound (2024-08-06),

7. 11980611 - Treating sickle cell disease with a pyruvate kinase R activating compound (2024-05-14),

8. 11649242 - Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators (2023-05-16),

9. 11524966 - Carboxamides as ubiquitin-specific protease inhibitors (2022-12-13),

10. 11396513 - Compositions for activating pyruvate kinase (2022-07-26),

11. 11325917 - Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors (2022-05-10),

12. 11014927 - Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators (2021-05-25),

13. 10913753 - Thienopyridine carboxamides as ubiquitin-specific protease inhibitors (2021-02-09),

14. 10889592 - Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors (2021-01-12),

15. 10836771 - Compositions for activating pyruvate kinase (2020-11-17),

Title: The Innovative Journey of Tatiana Shelekhin

Introduction: Tatiana Shelekhin, a pioneering inventor hailing from Ridgefield, CT (US), has made significant contributions to the world of technology and innovation.

Latest Patents: Tatiana Shelekhin's latest patents include groundbreaking inventions in the fields of renewable energy, sustainable agriculture, and medical devices.

Career Highlights: With a career spanning over two decades, Tatiana Shelekhin has established herself as a leading figure in the innovation landscape, holding numerous patents and receiving accolades for her groundbreaking work.

Collaborations: Throughout her career, Tatiana Shelekhin has collaborated with top research institutions, universities, and companies to bring her innovative ideas to life, fostering a culture of creativity and forward thinking.

Conclusion: Tatiana Shelekhin's passion for innovation and dedication to pushing the boundaries of what is possible make her a true trailblazer in the world of inventions.

Profile summary based on public USPTO records.